ADAR1 Capital Management, LLC
SEC CIK 1940272 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| INM | InMed Pharmaceuticals Inc. | 10% | 892.1K | $841.2K | — | 3 | 2026-05-19 | 2026-09-14 |
| TENX | TENAX THERAPEUTICS, INC. | 10% | 6.52M | $4.80M | — | 3 | 2026-08-20 | 2026-09-03 |
| NXTC | NextCure, Inc. | 10% | 722.4K | $1.71M | — | 2 | 2026-07-27 | 2026-07-30 |
| RLYB | Rallybio Corp | 10% | 926.4K | $4.23M | — | 4 | 2026-05-04 | 2026-05-18 |
| PVLA | PALVELLA THERAPEUTICS, INC. | 10% | 129.6K | $92.3K | — | 1 | 2024-08-09 | 2024-08-09 |
Most active insiders at INM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ADAR1 Capital Management, LLC | 10% | $841.2K | — |
| 2 | Vivo Opportunity, LLC | 10% | $433.5K | — |
Transactions 13
Purchase Sale Sale after option exercise All abbreviations
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-09-16 18:58 | 2026-09-14+ | INM | InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.30 | +91.1K | 892.1K | +11% | +$118.1K |
| I | 2026-09-08 17:16 | 2026-09-03 | TENX | TENAX THERAPEUTICS, INC. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.78 | +900.0K | 6.52M | +16% | +$1.60M |
| MI | 2026-09-02 17:52 | 2026-08-31+ | TENX | TENAX THERAPEUTICS, INC. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.79 | +770.3K | 5.62M | +16% | +$1.38M |
| MI | 2026-08-24 18:12 | 2026-08-20+ | TENX | TENAX THERAPEUTICS, INC. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.77 | +1.03M | 4.85M | +27% | +$1.81M |
| MI | 2026-08-03 17:53 | 2026-07-30+ | NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $4.93 | +329.2K | 722.4K | +84% | +$1.62M |
| MI | 2026-07-29 18:18 | 2026-07-27+ | NXTC | NextCure, Inc. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $4.98 | +17.6K | 393.3K | +5% | +$87.7K |
| I | 2026-07-17 19:29 | 2026-07-15 | INM | InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.55 | +1,000 | 801.0K | +0.1% | +$1,555 |
| MI | 2026-05-21 17:08 | 2026-05-19 | INM | InMed Pharmaceuticals Inc. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $1.54 | +468.6K | 800.0K | +141% | +$721.5K |
| MI | 2026-05-20 20:45 | 2026-05-18+ | RLYB | Rallybio Corp | ADAR1 Capital Management, LLC | 10% | P - Purchase | $13.98 | +16.2K | 926.4K | +2% | +$226.6K |
| MI | 2026-05-15 20:49 | 2026-05-13+ | RLYB | Rallybio Corp | ADAR1 Capital Management, LLC | 10% | P - Purchase | $13.99 | +79.6K | 910.1K | +10% | +$1.11M |
| MI | 2026-05-13 21:22 | 2026-05-11+ | RLYB | Rallybio Corp | ADAR1 Capital Management, LLC | 10% | P - Purchase | $14.00 | +50.8K | 830.6K | +7% | +$711.1K |
| MI | 2026-05-06 21:32 | 2026-05-04+ | RLYB | Rallybio Corp | ADAR1 Capital Management, LLC | 10% | P - Purchase | $13.97 | +155.9K | 779.8K | +25% | +$2.18M |
| MI | 2024-08-12 | 2024-08-09+ | PVLA | PALVELLA THERAPEUTICS, INC. | ADAR1 Capital Management, LLC | 10% | P - Purchase | $15.38 | +6,000 | 129.6K | +5% | +$92.3K |